STOCK TITAN

Elanco Animal Health (NYSE: ELAN) grants CFO deferred stock units

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc reported that EVP and CFO Robert M. VanHimbergen received a grant of 7.9093 deferred stock units on July 24, 2026 at $24.91 per unit. Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan. After this compensation-related grant, he holds 124.6979 deferred stock units directly.

Positive

  • None.

Negative

  • None.
Insider VanHimbergen Robert M
Role EVP and CFO
Type Security Shares Price Value
Grant/Award Deferred Stock Units F1, F2 7.9093 $24.91 $197.02
Holdings After Transaction: Deferred Stock Units — 124.6979 shares (Direct)
Footnotes (2)
  1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Deferred stock units granted 7.9093 units Grant to EVP and CFO Robert M. VanHimbergen on July 24, 2026
Grant price $24.9100 per unit Price used for the July 24, 2026 deferred stock unit award
Deferred stock units after grant 124.6979 units Direct holdings of deferred stock units by the EVP and CFO following the grant
Underlying common stock 7.9093 shares Shares of Elanco common stock linked to the new deferred stock units
Transaction code A Classified as a grant, award, or other acquisition of derivative securities
Deferred Stock Units financial
"security_title: Deferred Stock Units; each represents one share or cash equivalent"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Executive Deferral and Stock Match Plan financial
"settle in cash or shares ... in accordance with Executive Deferral and Stock Match Plan"
cash equivalent financial
"represents the right to receive one share of Company common stock or the cash equivalent"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Elanco Animal Health (ELAN) report for its CFO?

Elanco Animal Health reported that EVP and CFO Robert M. VanHimbergen received a grant of 7.9093 deferred stock units on July 24, 2026 at $24.91 per unit as stock-based compensation.

How many deferred stock units does the Elanco (ELAN) CFO hold after this grant?

Following the July 24, 2026 award, Elanco’s EVP and CFO Robert M. VanHimbergen directly holds 124.6979 deferred stock units, each linked to one share of Elanco common stock or its cash equivalent.

What do the deferred stock units in the Elanco (ELAN) Form 4 represent?

Each deferred stock unit reported for Elanco’s CFO represents the right to receive one share of company common stock or the cash equivalent, rather than immediate ownership of shares at the grant date.

When will the Elanco (ELAN) CFO’s deferred stock units settle?

The deferred stock units for Elanco’s CFO will settle in cash or shares after termination of employment or during a specified future year, in line with the company’s Executive Deferral and Stock Match Plan.

Was the Elanco (ELAN) CFO’s deferred stock unit grant an open-market purchase?

No. The transaction is coded as an award or other acquisition of deferred stock units, indicating stock-based compensation rather than an open-market share purchase by Elanco’s CFO.

Are the Elanco (ELAN) CFO’s deferred stock units tied to a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not checked, so this grant is not affirmatively identified as made under a Rule 10b5-1 or similar pre-arranged trading plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
VanHimbergen Robert M

(Last)(First)(Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
450 ELANCO CIRCLE

(Street)
INDIANAPOLIS INDIANA 46221

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)07/24/2026A7.9093 (2) (2)Common Stock7.9093$24.91124.6979D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen07/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)